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Background: Successful stem cell delivery and biodistribution are pivotal factors for efficient stem cell therapy. We used fluorescent microsphere 
particles to simulate cell retention and biodistribution after cardiac regenerative therapy. Fibrinogen was evaluated to augment particle retention.
Methods: Fluorescent microspheres (5,0*10^5; d=10μm) were transplanted into 26 mice hearts in 5 groups (A=injection in PBS into explanted 
hearts, B-E= injection after LAD ligation in situ, B-C=PBS, D-E=fibrinogen). Hearts were explanted after 10min (groups B+D) or 3days (groups C+E), 
respectively. Direct macroscopic fluorescence bioimaging was performed using a Xenogen® IVIS Lumina-System.
Results: Compared to ex situ injection, the in situ delivery in PBS showed a 90% decline in particle retention (group A = 3,2*10^5 vs. group B = 
0,3*105; p<0,01), indicating immediate loss during injection mainly through venous drainage into the lungs. Further particle loss into the lungs was 
observed until POD3 (p<0,05). Cardiac particle retention could be improved using fibrinogen as a carrier substance (group D = 1,1*10^5; D vs. B: 
p<0,05).
Conclusions: Beating heart application techniques are associated with a massive loss of fluorescent microspheres. We introduce a reliable tool 
to analyse retention and biodistribution of cell-like particles after injection into infarcted myocardium. Fibrinogen improves cardiac microsphere 
retention and should be considered the carrier of choice for intramyocardial stem cell delivery.
